Summary Of Revumenib-API-Small Molecules

Chemical Name

Revumenib

CAS No.

2169919-21-3

Molecular Formula

C32H47FN6O4S

Innovator

Developer

Indication

Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia

Therapeutic Area

Oncology

Market Status

Investigational

Approval Year

Patent Expiry